These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 17448573

  • 1. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
    da Costa Leite LF, Veras Mourão RH, de Lima Mdo C, Galdino SL, Hernandes MZ, de Assis Rocha Neves F, Vidal S, Barbe J, da Rocha Pitta I.
    Eur J Med Chem; 2007 Oct; 42(10):1263-71. PubMed ID: 17448573
    [Abstract] [Full Text] [Related]

  • 2. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
    Chakrabarti R, Misra P, Vikramadithyan RK, Premkumar M, Hiriyan J, Datla SR, Damarla RK, Suresh J, Rajagopalan R.
    Eur J Pharmacol; 2004 May 03; 491(2-3):195-206. PubMed ID: 15140637
    [Abstract] [Full Text] [Related]

  • 3. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
    Lee HW, Kim BY, Ahn JB, Kang SK, Lee JH, Shin JS, Ahn SK, Lee SJ, Yoon SS.
    Eur J Med Chem; 2005 Sep 03; 40(9):862-74. PubMed ID: 15908051
    [Abstract] [Full Text] [Related]

  • 4. Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
    Humphries PS, Bailey S, Almaden JV, Barnum SJ, Carlson TJ, Christie LC, Do QQ, Fraser JD, Hess M, Kellum J, Kim YH, McClellan GA, Ogilvie KM, Simmons BH, Skalitzky D, Sun S, Wilhite D, Zehnder LR.
    Bioorg Med Chem Lett; 2006 Dec 01; 16(23):6120-3. PubMed ID: 16973358
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
    Kumar A, Maurya RA, Sharma S, Ahmad P, Singh AB, Tamrakar AK, Srivastava AK.
    Bioorg Med Chem; 2009 Jul 15; 17(14):5285-92. PubMed ID: 19500993
    [Abstract] [Full Text] [Related]

  • 6. Dual PPAR-alpha and -gamma activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential.
    Madhavan GR, Chakrabarti R, Reddy KA, Rajesh BM, Balraju V, Rao PB, Rajagopalan R, Iqbal J.
    Bioorg Med Chem; 2006 Jan 15; 14(2):584-91. PubMed ID: 16198573
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological activity of novel acridinylidene and benzylidene thiazolidinediones.
    Mourão RH, Silva TG, Soares AL, Vieira ES, Santos JN, Lima MC, Lima VL, Galdino SL, Barbe J, Pitta IR.
    Eur J Med Chem; 2005 Nov 15; 40(11):1129-33. PubMed ID: 16040159
    [Abstract] [Full Text] [Related]

  • 8. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB, Bhushan V, Rao BP, Madhavan GR, Murali N, Rao KN, Reddy AK, Rajesh BM, Reddy PG, Chakrabarti R, Vikramadithyan RK, Rajagopalan R, Mamidi RN, Jajoo HK, Subramaniam S.
    J Med Chem; 1998 May 07; 41(10):1619-30. PubMed ID: 9572887
    [Abstract] [Full Text] [Related]

  • 9. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
    Reddy KA, Lohray BB, Bhushan V, Reddy AS, Rao Mamidi NV, Reddy PP, Saibaba V, Reddy NJ, Suryaprakash A, Misra P, Vikramadithyan RK, Rajagopalan R.
    J Med Chem; 1999 Aug 26; 42(17):3265-78. PubMed ID: 10464013
    [Abstract] [Full Text] [Related]

  • 10. Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups--new classes of PPAR gamma/delta and PPAR alpha/gamma/delta agonists.
    Cantin LD, Liang S, Ogutu H, Iwuagwu CI, Boakye K, Bullock WH, Burns M, Clark R, Claus T, delaCruz FE, Daly M, Ehrgott FJ, Johnson JS, Keiper C, Livingston JN, Schoenleber RW, Shapiro J, Town C, Yang L, Tsutsumi M, Ma X.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):1056-61. PubMed ID: 17157013
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and antihyperglycemic evaluation of various protoberberine derivatives.
    Bian X, He L, Yang G.
    Bioorg Med Chem Lett; 2006 Mar 01; 16(5):1380-3. PubMed ID: 16359864
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands.
    Warshawsky AM, Alt CA, Brozinick JT, Harkness AR, Hawkins ED, Henry JR, Matthews DP, Miller AR, Misener EA, Montrose-Rafizadeh C, Rhodes GA, Shen Q, Vance JA, Udodong UE, Wang M, Zhang TY, Zink RW.
    Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6328-33. PubMed ID: 17005394
    [Abstract] [Full Text] [Related]

  • 13. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Almanza-Pérez JC, Román-Ramos R, Alarcón-Aguilar FJ, Hernández-Rosado JV, Moreno-Díaz H, Díaz-Coutiño D, Navarrete-Vázquez G.
    Chem Biol Drug Des; 2013 Apr 15; 81(4):474-83. PubMed ID: 23289972
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
    Avupati VR, Yejella RP, Akula A, Guntuku GS, Doddi BR, Vutla VR, Anagani SR, Adimulam LS, Vyricharla AK.
    Bioorg Med Chem Lett; 2012 Oct 15; 22(20):6442-50. PubMed ID: 22981328
    [Abstract] [Full Text] [Related]

  • 15. Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
    Humphries PS, Almaden JV, Barnum SJ, Carlson TJ, Do QQ, Fraser JD, Hess M, Kim YH, Ogilvie KM, Sun S.
    Bioorg Med Chem Lett; 2006 Dec 01; 16(23):6116-9. PubMed ID: 16979341
    [Abstract] [Full Text] [Related]

  • 16. Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
    Lohray BB, Bhushan V, Reddy AS, Rao PB, Reddy NJ, Harikishore P, Haritha N, Vikramadityan RK, Chakrabarti R, Rajagopalan R, Katneni K.
    J Med Chem; 1999 Jul 15; 42(14):2569-81. PubMed ID: 10411477
    [Abstract] [Full Text] [Related]

  • 17. Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists.
    Oon Han H, Kim SH, Kim KH, Hur GC, Joo Yim H, Chung HK, Ho Woo S, Dong Koo K, Lee CS, Sung Koh J, Kim GT.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):937-41. PubMed ID: 17157019
    [Abstract] [Full Text] [Related]

  • 18. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
    Reddy KA, Lohray BB, Bhushan V, Bajji AC, Reddy KV, Reddy PR, Krishna TH, Rao IN, Jajoo HK, Rao NV, Chakrabarti R, Dileepkumar T, Rajagopalan R.
    J Med Chem; 1999 Jun 03; 42(11):1927-40. PubMed ID: 10354401
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones.
    Khazi MI, Belavagi NS, Kim KR, Gong YD, Khazi IA.
    Chem Biol Drug Des; 2013 Aug 03; 82(2):147-55. PubMed ID: 23581650
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, biological evaluation and molecular docking studies of novel 3,5-disubstituted 2,4-thiazolidinediones derivatives.
    Ranjan Srivastava A, Bhatia R, Chawla P.
    Bioorg Chem; 2019 Aug 03; 89():102993. PubMed ID: 31129500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.